Rua Bioscience Limited — Share Issue/Capital Change 2025

Dec 19, 2025

Capital Change Notice

==> picture [78 x 33] intentionally omitted <==

Section 1: Issuer information

Name of issuer	Rua Bioscience Limited
NZX ticker code	RUA
Class of financial product	Ordinary shares
ISIN (If unknown, check on NZX website)	NZRUAE0004S1
Currency	NZ$
Section 2: Capital change details
Number issued/acquired/redeemed	92,627,157
Nominal value (if any)	N/A
Issue/acquisition/redemption price per security	$0.025
Nature of the payment (for example, cash or other	Cash
consideration)
Amount paid up (if not in full)	Paid in full
Percentage of total class of Financial Products	35.8%
issued/acquired/redeemed/ (calculated on the number of
Financial Products of the Class, excluding any Treasury Stock,
in existence)1
For an issue of Convertible Financial Products or Options, the	N/A
principal terms of Conversion (for example the Conversion
price and Conversion date and the ranking of the Financial
Product in relation to other Classes of Financial Product) or the
Option (for example, the exercise price and exercise date)
Reason for issue/acquisition/redemption and specific authority	Allotment of new ordinary
for issue/acquisition/redemption/ (the reason for change must	shares pursuant to a pro-rata 1
be identified here)	for 3 renounceable rights offer
	announced on 3 November
	2025, and a placement of
	shares as a result of
	oversubscription.
Total number of Financial Products of the Class after the	338,041,705 ordinary shares.
issue/acquisition/redemption/Conversion (excluding Treasury
Stock) and the total number of Financial Products of the Class
held as Treasury Stock after the issue/acquisition/redemption.
In the case of an acquisition of shares, whether those shares	N/A
are to be held as treasury stock
Specific authority for the issue, acquisition, or redemption,	Board resolutions and NZX
including a reference to the rule pursuant to which the issue,	Listing Rule 4.3.1(a) and 4.4
acquisition, or redemption is made	and 4.5
Terms or details of the issue, acquisition, or redemption (for	Issue of ordinary shares which
example: restrictions, escrow arrangements)	rank equally with all other fully
	paid ordinary shares

1 The percentage is to be calculated immediately before the issue, acquisition, redemption or Conversion.

Date of issue/acquisition/redemption		18/12/2025
Section 3: Authority for this announcement and contact	person
Name of person authorised to make this announcement		Paul Naske
Contact person for this announcement		Paul Naske
Contact phone number		021 445 154
Contact email address		Paul.naske@ruabio.com
Date of release through MAP		19/12/2025